Literature DB >> 2829379

Pharmacokinetics of heparin and low molecular weight heparin fragment (Fragmin) in rabbits with impaired renal or metabolic clearance.

M Palm1, C Mattsson.   

Abstract

The kinetics and tissue distribution of 3H-heparin and a 3H-labelled low molecular weight heparin fragment were compared in normal rabbits as well as in rabbits with blocked renal function or reticuloendothelial system (RES). Radioactivity in plasma, urine, liver and kidneys, as well as anti-FXa activity in plasma were determined. The plasma elimination of heparin was, when compared to normal controls, prolonged both in rabbits with renal dysfunction as well as in rabbits with blocked RES, while renal dysfunction was the only parameter that significantly prolonged the plasma half-life of Fragmin. Studies on tissue distribution in normal rabbits revealed that about 60 per cent of the radioactive heparin dose accumulated in the liver and kidney three hours after the injection, whereas the corresponding value was less than 10 per cent for the Fragmin-derived radioactivity. The recovery of radioactivity in urine within three hours was 5 and 35 per cent of the dose, respectively, for 3H-heparin and 3H-Fragmin. It is concluded from the present study that the rapid plasma elimination of heparin in the rabbit (t1/2 = 17 minutes) is mainly due to a high tissue distribution (liver and kidney) while the plasma elimination of Fragmin (t1/2 = 28 minutes) is mainly caused by renal excretion.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 2829379

Source DB:  PubMed          Journal:  Thromb Haemost        ISSN: 0340-6245            Impact factor:   5.249


  17 in total

Review 1.  Parenteral anticoagulants: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines.

Authors:  David A Garcia; Trevor P Baglin; Jeffrey I Weitz; Meyer Michel Samama
Journal:  Chest       Date:  2012-02       Impact factor: 9.410

2.  The effects of heparin and related molecules on vascular permeability and neutrophil accumulation in rabbit skin.

Authors:  Helen Jones; William Paul; Clive P Page
Journal:  Br J Pharmacol       Date:  2002-01       Impact factor: 8.739

3.  The role of liver and kidney on the pharmacokinetics of a recombinant amino terminal fragment of bactericidal/permeability-increasing protein in rats.

Authors:  R J Bauer; K Der; N Ottah-Ihejeto; J Barrientos; A H Kung
Journal:  Pharm Res       Date:  1997-02       Impact factor: 4.200

Review 4.  Initial anticoagulation in patients with pulmonary embolism: thrombolysis, unfractionated heparin, LMWH, fondaparinux, or DOACs?

Authors:  Jenneke Leentjens; Mike Peters; Anne C Esselink; Yvo Smulders; Cornelis Kramers
Journal:  Br J Clin Pharmacol       Date:  2017-07-09       Impact factor: 4.335

Review 5.  Dalteparin: an update of its pharmacological properties and clinical efficacy in the prophylaxis and treatment of thromboembolic disease.

Authors:  C J Dunn; B Jarvis
Journal:  Drugs       Date:  2000-07       Impact factor: 9.546

6.  Heavy Heparin: A Stable Isotope-Enriched, Chemoenzymatically-Synthesized, Poly-Component Drug.

Authors:  Brady F Cress; Ujjwal Bhaskar; Deepika Vaidyanathan; Asher Williams; Chao Cai; Xinyue Liu; Li Fu; Vandhana M-Chari; Fuming Zhang; Shaker A Mousa; Jonathan S Dordick; Mattheos A G Koffas; Robert J Linhardt
Journal:  Angew Chem Int Ed Engl       Date:  2019-04-01       Impact factor: 15.336

Review 7.  Dalteparin sodium. A review of its pharmacology and clinical use in the prevention and treatment of thromboembolic disorders.

Authors:  C J Dunn; E M Sorkin
Journal:  Drugs       Date:  1996-08       Impact factor: 9.546

8.  Rat and human HARE/stabilin-2 are clearance receptors for high- and low-molecular-weight heparins.

Authors:  Edward N Harris; Bruce A Baggenstoss; Paul H Weigel
Journal:  Am J Physiol Gastrointest Liver Physiol       Date:  2009-04-09       Impact factor: 4.052

9.  Characterization and cellular distribution of acidic peptide and oligosaccharide metal-binding compounds from kidneys.

Authors:  P F Predki; D M Whitfield; B Sarkar
Journal:  Biochem J       Date:  1992-02-01       Impact factor: 3.857

Review 10.  Heparin pharmacokinetics and pharmacodynamics.

Authors:  R J Kandrotas
Journal:  Clin Pharmacokinet       Date:  1992-05       Impact factor: 6.447

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.